Salk researchers show how two experimental Alzheimer’s drugs protect the brains of mice from other aspects of aging
In mouse models of Alzheimer’s disease, the investigational drug candidates known as CMS121 and J147 improve memory and slow the degeneration of brain cells. Now, Salk researchers have shown how these compounds can also slow aging in healthy older mice, blocking the damage to brain cells that normally occurs during aging and restoring the levels of specific molecules to those seen in younger brains.
The research, published last month in the journal eLife, suggests that the drug candidates may be useful for treating a broader array of conditions and points out a new pathway that links normal aging to Alzheimer’s disease.
“This study further validated these two compounds not only as Alzheimer’s drug candidates but also as potentially more widely useful for their anti-aging effects,” says Pamela Maher, a senior staff scientist at Salk and a co-corresponding author of the new paper.
Old age is the biggest risk factor for Alzheimer’s disease—above the age of 65, a person’s risk of developing the disease doubles about every five years. However, at a molecular level, scientists aren’t sure what occurs in the brain with aging that contributes to Alzheimer’s.
“The contribution of old age-associated detrimental processes to the disease has been largely neglected in Alzheimer’s disease drug discovery,” says Antonio Currais, a Salk staff scientist and first author of the new paper.
Maher and David Schubert, the head of Salk’s Cellular Neurobiology Lab, previously developed CMS121 and J147, variants of plant compounds with medicinal properties. Both compounds tested positive for their ability to keep neurons alive when exposed to cellular forms of stress related to aging and Alzheimer’s disease. Since then, the researchers have used the drug candidates to treat Alzheimer’s in animal models of the disease. But experiments revealing exactly how the compounds work suggested that they were targeting molecular pathways also known to be important in longevity and aging.
In the new research, Maher, Currais and their colleagues turned to a strain of mice that ages unusually fast. A subset of these mice was given CMS121 or J147 beginning at nine months old—the equivalent of late middle age in humans. After four months, the team tested the memory and behavior of the animals and analyzed genetic and molecular markers in their brains.
Not only did the animals given either of the drug candidates perform better on memory tests than mice that hadn’t received any treatment, but their brains showed differences at the cellular and molecular levels. In particular, expression of genes associated with the cell’s energy-generating structures called mitochondria was preserved by CMS121 and J147 with aging.
“The bottom line was that these two compounds prevent molecular changes that are associated with aging,” says Maher.
More detailed experiments showed that both drugs affected mitochondria by increasing levels of the chemical acetyl-coenzyme A (acetyl-coA). In isolated brain cells, when the researchers blocked an enzyme that normally breaks down acetyl-CoA, or when they added extra amounts of an acetyl-coA precursor, they saw the same beneficial effect on mitochondria and energy generation. The brain cells became protected against the normal molecular changes associated with aging.
“There was already some data from human studies that the function of mitochondria is negatively impacted in aging and that it’s worse in the context of Alzheimer’s,” says Maher. “This helps solidify that link.”
Maher and Currais are planning future experiments to test the effects of CMS121 and J147 on how other organs age. They also hope to use the new results to inform the development of new Alzheimer’s drugs; targeting other molecules in the acetyl-coA pathway may help treat the disease, they hypothesize.
“We are now using a variety of animal models to investigate how this neuroprotective pathway regulates specific molecular aspects of mitochondrial biology, and their effects on aging and Alzheimer’s,” says Currais.
Go deeper with Bing News on:
- Ringwood apartments: Plan to knock down ageing homes for five-storey Pitt St complexon February 28, 2021 at 6:02 pm
Safety fears have been raised over a boutique apartment complex planned near Ringwood railway station, which locals fear could lead to major congestion in the area.
- How do I talk to my ageing parents about finances?on February 28, 2021 at 7:14 am
Knowing how to talk to ageing parents about finances is never easy. We take a look at some useful strategies and questions to make the process easier.
- Susanna Reid on Piers Morgan, sexism and ageingon February 26, 2021 at 4:04 pm
Susanna Reid has been reading about the importance of regular wake-up times to reduce the risk of long-term depression. This is not an option when your alarm gets you up at 3.50am four days a week so ...
- Fat loss may accelerate facial ageing: Is it irreversible?on February 26, 2021 at 7:10 am
When you lose weight, you shed kilos from every inch of your body, including your face. But did you know that losing face fat can lead to ageing? A study featured in the February issue of Plastic and ...
- Argentinian winery Wapisa reveals ‘stunning’ results of ocean wine ageing experimenton February 26, 2021 at 2:41 am
Argentinian winery Wapisa has revealed the "stunning" results of its nine-month underwater wine ageing experiment.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Artisan Meat Lab Launches The Dry Age Bags For Meat Agingon February 28, 2021 at 11:40 pm
Providers of innovative dry-aging meat kit, Artisan Meat Lab, announces the launch of Dry Age Bags, a solution designed to help people to create custom dry-aged steak at home ...
- Flexible retirement an option for 'aging society'on February 28, 2021 at 11:14 pm
Delayed retirement means postponing the retirement age, and the advantages of this can be summed up in three ways. It is good for the sustainability of the pension fund system, the stability of the ...
- Time to update aging estate documentson February 28, 2021 at 10:00 pm
A: Most estate planners recommend that the documents you mentioned should be reviewed every five to 10 years. Importantly, both powers of attorney and the directive to physicians form have changed ...
- China's aging population is a bigger challenge than its 'one-child' policy, economists sayon February 28, 2021 at 5:44 pm
Authorities have recently rolled back the one-child policy. But economists say other changes are needed for boosting growth as China's population rapidly ages.
- This MVP Exclusive Deal Helps You Save Big on Anti-Aging Skincareon February 28, 2021 at 6:00 am
Welcome to MVP Deals, where we're offering up some major, limited-time discounts on the coolest gear and equipment, exclusive to Men's Health MVPs. Along with our premium videos, workout programs, and ...